Fertility Testing Explained: A Complete Guide for Couples in Australia

When you're ready to start a family, knowledge is one of your most powerful tools. Fertility testing — for both partners — gives you a clear picture of your reproductive health, identifies any challenges early, and helps you and your healthcare provider map the most effective path forward. Whether you've just started trying to conceive, have been trying for some months without success, or are simply curious about your baseline fertility, this comprehensive guide covers everything you need to know about fertility testing in Australia.

Why Fertility Testing Matters — and When to Pursue It

Infertility is defined as the inability to conceive after 12 months of regular unprotected sexual intercourse (or 6 months if the female partner is 35 or older). By this definition, approximately 1 in 6 Australian couples experience infertility at some point — a figure consistent with global data.

However, fertility testing doesn't need to wait until a clinical diagnosis of infertility. Testing earlier provides valuable baseline data, allows time to address any identified issues, and can reduce the emotional toll of prolonged uncertainty. The Australian clinical guidelines from the Fertility Society of Australia (FSA) and RANZCOG recommend earlier evaluation for women over 35, those with known risk factors (irregular cycles, endometriosis, PCOS, prior surgery, or a male partner with known reproductive issues), or couples who feel ready to seek answers.

Fertility is a shared responsibility. Research consistently shows that male factor issues contribute to approximately 40–50% of all infertility cases. Yet male partners are often the last to be tested. A comprehensive fertility workup evaluates both partners simultaneously — this is the most efficient and evidence-based approach.

Fertility Testing for Women: What's Involved

A thorough female fertility evaluation typically begins with a detailed medical history and proceeds through a series of tests:

Hormonal Blood Tests

Blood tests assess the hormones that govern the menstrual cycle and ovarian function:

• Anti-Müllerian Hormone (AMH): Reflects ovarian reserve — the size of the remaining egg pool. Can be drawn at any point in the cycle. Low AMH suggests diminished reserve; results must be interpreted by a clinician alongside other markers.
• Day 2–3 FSH (Follicle Stimulating Hormone): Elevated FSH on day 2–3 of the cycle indicates the pituitary is working harder to stimulate ovaries, suggesting reduced reserve.
• Day 2–3 LH (Luteinising Hormone): Assessed alongside FSH; elevated LH relative to FSH (LH:FSH ratio > 2:1) can suggest PCOS.
• Oestradiol (E2): Measured alongside FSH; elevated early-cycle E2 can suppress FSH, masking diminished reserve.
• Progesterone (Day 21): Measured approximately 7 days after ovulation to confirm that ovulation has occurred and to assess luteal phase adequacy.
• Prolactin: Elevated prolactin (hyperprolactinaemia) can suppress ovulation and is a common, treatable cause of irregular cycles.
• Thyroid function (TSH, T3, T4): Thyroid disorders — both hypo- and hyperthyroidism — can significantly impair ovulation and increase miscarriage risk. Subclinical hypothyroidism (TSH 2.5–4.0 mIU/L) is now increasingly treated in those trying to conceive.
• Androgens (testosterone, DHEAS): Elevated androgens can indicate PCOS or adrenal dysfunction.
• Fasting insulin and glucose: Important for assessing insulin resistance, which is common in PCOS and impairs ovulation.

Pelvic Ultrasound

Transvaginal ultrasound is the gold standard for visualising pelvic anatomy. It can identify:

• Antral follicle count (AFC) — a direct measure of ovarian reserve
• Polycystic ovarian morphology (PCOM) — multiple small follicles characteristic of PCOS
• Uterine fibroids — which may distort the uterine cavity and impair implantation
• Endometrial polyps — growths in the uterine lining that can interfere with embryo attachment
• Structural anomalies — uterine septum, bicornuate uterus, or other congenital variations
• Ovarian cysts or endometriomas (indicative of endometriosis)

Tubal Assessment

The fallopian tubes must be open (patent) for natural conception. Tubal blockage — often caused by prior infection, endometriosis, or surgical scarring — is assessed via:

• HyCoSy (hysterosalpingo-contrast sonography): An ultrasound-guided procedure where fluid is passed through the tubes to assess patency. Well-tolerated in most women, with no radiation exposure.
• HSG (hysterosalpingography): An X-ray procedure using radio-opaque contrast dye to outline the uterine cavity and tubes. Also allows visualisation of uterine shape and any intrauterine abnormalities.
• Laparoscopy: Surgical investigation under general anaesthesia, used when endometriosis or significant tubal disease is suspected and cannot be adequately assessed by less invasive means.

Uterine Cavity Assessment

When ultrasound or HSG identifies potential intrauterine abnormalities, hysteroscopy (direct visualisation of the uterine cavity via a camera) provides definitive assessment and, in many cases, treatment in the same procedure.

Fertility Testing for Men: The Semen Analysis and Beyond

The semen analysis (SA) is the cornerstone of male fertility investigation and provides a wealth of information about sperm health:

Standard Semen Analysis Parameters (WHO 2021 Reference Values):

• Volume: ≥1.4 mL per ejaculate
• Total sperm count: ≥39 million per ejaculate
• Concentration: ≥16 million sperm per millilitre
• Progressive motility: ≥30% of sperm moving progressively forward
• Total motility: ≥42%
• Morphology (strict Kruger criteria): ≥4% normal forms
• Vitality: ≥54% live sperm

These reference values were updated from the 2010 edition of the WHO Laboratory Manual and represent the 5th percentile of fertile men — meaning values below these thresholds are associated with reduced (not zero) fertility.

A semen analysis should be performed after 2–5 days of sexual abstinence, on a fresh sample produced at or delivered promptly to the laboratory within 30–60 minutes at body temperature. A single abnormal result warrants a repeat test (ideally 2–3 months later, given the 72-day sperm production cycle) before drawing conclusions.

Advanced Sperm Testing

When standard SA results are abnormal, or when recurrent pregnancy loss occurs despite normal SA, additional testing may be recommended:

• Sperm DNA fragmentation index (DFI): Measures the proportion of sperm with DNA strand breaks. High DFI (>25–30%) is associated with reduced fertilisation rates, poor embryo development, and increased miscarriage risk. Testing via SCSA, TUNEL, or Comet assay.
• Morphology staining: More detailed assessment of sperm shape under high magnification.
• Sperm antibody testing: Anti-sperm antibodies can agglutinate sperm or impair their function.
• Sperm culture: Assessment for bacterial infection if clinical features suggest epididymitis or prostatitis.

Male Hormonal and Physical Assessment

If sperm count is very low or absent (azoospermia), or if there are clinical features suggesting endocrine dysfunction:

• FSH, LH, testosterone, prolactin, thyroid function
• Physical examination by a urologist or andrologist to identify varicocele, testicular volume, and epididymal abnormalities
• Genetic testing: karyotype, Y chromosome microdeletion analysis, and CFTR mutation testing (for men with congenital absence of the vas deferens)
• Testicular biopsy in cases of azoospermia to distinguish obstructive from non-obstructive causes

Understanding Your Results: Common Fertility Diagnoses

Polycystic Ovary Syndrome (PCOS): Affecting approximately 1 in 10 women of reproductive age, PCOS is the most common cause of ovulatory infertility. Diagnosed via Rotterdam criteria (at least 2 of 3: polycystic ovarian morphology on ultrasound, clinical or biochemical hyperandrogenism, and oligo- or anovulation). Highly treatable — lifestyle modification, metformin, and ovulation-inducing medications are all effective approaches.

Diminished Ovarian Reserve (DOR): Low AMH and/or AFC, often with elevated FSH. Does not preclude natural conception but may indicate benefit from prompt investigation and consideration of fertility preservation or treatment.

Tubal Factor Infertility: Blocked or damaged tubes, often resulting from pelvic inflammatory disease (PID), endometriosis, or prior surgery. IVF bypasses tubal factor entirely and is often the recommended treatment.

Endometriosis: Affecting approximately 10% of women of reproductive age, endometriosis can impair fertility through multiple mechanisms — ovarian reserve reduction (from endometriomas), tubal adhesions, altered immune environment, and impaired implantation. Often under-diagnosed due to the non-specific nature of symptoms and the need for laparoscopy for definitive diagnosis.

Male Factor Infertility: Encompasses oligospermia (low count), asthenospermia (low motility), teratospermia (poor morphology), or combinations thereof (OAT syndrome). Treatment ranges from lifestyle optimisation and antioxidant supplementation to hormonal therapy, surgical correction of varicocele, or assisted reproduction (IUI, ICSI).

Navigating the Australian Healthcare System for Fertility Testing

In Australia, much of the initial fertility investigation is accessible through the public healthcare system with appropriate referrals. Key pathways include:

• GP referral: Your general practitioner can order most initial blood tests and refer you for pelvic ultrasound on Medicare. A semen analysis can also be requested by a GP.
• Gynaecologist or reproductive specialist: For more complex investigation (HyCoSy, HSG, hysteroscopy) or if initial tests indicate an issue, your GP can provide a referral to a specialist gynaecologist or fertility specialist.
• Fertility clinics: Most major Australian cities have IVF and fertility centres that offer comprehensive evaluation. Some Medicare rebates apply for investigation and certain treatments. Specific Medicare item numbers cover fertility procedures under defined criteria.
• Private health insurance: Hospital cover may fund some surgical procedures related to fertility investigation (laparoscopy, hysteroscopy). Check your policy carefully.

The Fertility Society of Australia's website (www.fertilitysociety.com.au) provides a directory of accredited fertility clinics and reproductive specialists across all states and territories.

Supporting Fertility While You Test and Treat

Waiting for test results and making treatment decisions is a period of significant uncertainty. Taking proactive steps to support your reproductive health during this time has both clinical and psychological benefits.

Evidence-based strategies include:

• Start or optimise a preconception supplement: For women, a supplement providing methylfolate, CoQ10, vitamin D, iron, omega-3 DHA, B12, and zinc. For men, antioxidant supplementation targeting sperm health: CoQ10, vitamin C, E, zinc, selenium, and L-carnitine.
• Dietary optimisation: The Mediterranean diet pattern has the strongest evidence base for fertility. Prioritise colourful vegetables, whole grains, legumes, oily fish, and olive oil. Minimise processed foods, refined sugar, and trans fats.
• Moderate, consistent exercise: Supports hormonal health and weight management in both partners. Avoid overtraining in either direction.
• Stop smoking and limit alcohol: Both partners. These are the most impactful modifiable lifestyle factors for fertility.
• Optimise sleep: 7–9 hours per night supports LH and melatonin regulation, both relevant to fertility.
• Manage stress: Chronic stress elevates cortisol, which can suppress GnRH and impair ovulation. Mind-body practices, therapy, and community support all have roles.

FAQ: Fertility Testing in Australia

Does Medicare cover fertility testing in Australia?

Yes, many initial fertility tests are covered under Medicare when requested by a GP or specialist. These include hormone blood tests (AMH, FSH, LH, thyroid), pelvic ultrasound, and semen analysis. HyCoSy, HSG, hysteroscopy, and laparoscopy may require referral to a specialist and attract rebates under specific Medicare item numbers. Private fertility clinics may also have fee-for-service costs on top of Medicare rebates.

How long does a fertility workup take?

Basic blood tests and ultrasound can be completed within a single menstrual cycle. Tubal testing and specialist review may add another 2–4 weeks depending on clinic availability. A comprehensive evaluation — including results, specialist review, and follow-up — typically takes 4–8 weeks from initial GP consultation to having a plan.

Can I get my AMH tested privately without a doctor's referral?

AMH testing is available privately in Australia without a referral through some pathology providers and online testing services. However, results should always be interpreted in the context of a full clinical assessment — a GP or fertility specialist can provide the necessary context and guidance.

What's the difference between a semen analysis and a sperm DNA fragmentation test?

A standard semen analysis measures sperm count, motility, morphology, and volume — the basic parameters of sperm function. Sperm DNA fragmentation testing evaluates the integrity of the genetic material within sperm. A man can have normal SA results but high DNA fragmentation, which may contribute to poor embryo development and recurrent miscarriage. DFI testing is not routinely offered but is increasingly available at fertility clinics.

I've been trying for 8 months and I'm 32. Should I seek testing?

Technically, clinical guidelines suggest waiting 12 months at age 32. However, if you're concerned, there is no harm in seeking baseline testing sooner. Many GPs will initiate a workup after 6 months for motivated patients. If you have any known risk factors (irregular cycles, endometriosis, prior pelvic infection, or a male partner with potential issues), earlier evaluation is appropriate.

My GP referred me to a gynaecologist. Do I need a fertility specialist instead?

It depends. A gynaecologist is well-placed to manage structural issues like fibroids, polyps, or endometriosis. A fertility specialist (reproductive endocrinologist) is more appropriate if you're considering IVF, IUI, or if the issue involves ovarian reserve or complex hormonal factors. In many cases, a gynaecologist will refer you on to a fertility clinic if the investigation reveals significant issues. Don't hesitate to ask for a referral to the appropriate specialist.

Can a normal semen analysis mean there are no male factor issues?

A normal SA is reassuring but not a definitive all-clear. Sperm DNA fragmentation, anti-sperm antibodies, and sperm function beyond basic parameters are not captured by a standard SA. If there are unexplained pregnancy losses or failed IVF cycles despite good embryo quality, further sperm testing may be warranted.

How does endometriosis affect fertility testing results?

Endometriosis can lower AMH (when endometriomas are present), cause tubal occlusion (visible on HyCoSy or HSG), and distort uterine anatomy. It may not always be visible on ultrasound — definitive diagnosis requires laparoscopy. If your clinician suspects endometriosis based on symptoms (painful periods, pain with intercourse, cyclical bowel or bladder symptoms) and testing, laparoscopy may be recommended even when standard tests appear normal.

What should I do if my fertility tests come back completely normal?

"Unexplained infertility" — where both partners have apparently normal test results — accounts for approximately 25–30% of infertility cases. In this situation, treatment options include expectant management (continuing to try naturally with lifestyle optimisation), IUI, or IVF with or without additional investigation. A fertility specialist can guide next steps based on your age, duration of infertility, and personal preferences.

Are fertility supplements worth taking while undergoing testing?

Yes. A quality preconception supplement for both partners is a low-risk, evidence-informed step that can be started immediately regardless of where you are in the testing process. Nutrients like CoQ10, folate, zinc, and selenium support egg and sperm health over the 3-month development cycle. Starting supplementation early maximises the potential benefit by the time you're ready to conceive or begin treatment.